The Effect of L-Carnitin in Treatment of Migraine
Phase 3
Recruiting
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20190128042533N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
Children with migraine whose disease has recently been diagnosed with the International Headache Society (IHS) criteria.
Not currently under any preventive treatment.
Have a migraine headache for at least once a week.
Exclusion Criteria
Patients who have more than four headache attacks in a month (severe migraines)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache severity. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Pediatric Migraine Disability Assessment Scale.;Headache frequency. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: interview.;Headache duration. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Interview.
- Secondary Outcome Measures
Name Time Method Medication side effects. Timepoint: Two weeks, one month, three months after begining of treatment. Method of measurement: Physical examination.